Emergent BioSolutions (EBS) Net Long-Term Debt Issued (Repaid) (2011 - 2026)
Emergent BioSolutions' Net Long-Term Debt Issued (Repaid) was $81.9 million in Q3 2026, compared with -$6.9 million a year earlier.
Powered by 
Analysis
Emergent BioSolutions (EBS) Net Long-Term Debt Issued (Repaid) (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Emergent BioSolutions' Net Long-Term Debt Issued (Repaid) was -$24.6 million through Sep 30, 2026; for FY2025, it came in at -$106.5 million.
- In earlier years, Net Long-Term Debt Issued (Repaid) was $85.8 million in FY2024, -$144.6 million in FY2023, $564.2 million in FY2022 and -$35.9 million in FY2021.
- The Q3 2026 figure marks the highest quarterly Net Long-Term Debt Issued (Repaid) since Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net LT Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | -1.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 9.98 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | -3.05 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | -19.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn | 81.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 81.90 Mn |
| Dec 31, 2025 | -99.60 Mn |
| Sep 30, 2025 | -6.90 Mn |
| Sep 30, 2024 | 28.70 Mn |
| Jun 30, 2024 | 11.00 Mn |
| Mar 31, 2024 | 46.10 Mn |
| Dec 31, 2023 | 16.10 Mn |
| Sep 30, 2023 | -3.90 Mn |
| Jun 30, 2023 | -148.40 Mn |
| Mar 31, 2023 | -8.40 Mn |
| Dec 31, 2022 | 351.50 Mn |
| Sep 30, 2022 | -8.40 Mn |
| Jun 30, 2022 | -8.40 Mn |
| Mar 31, 2022 | -8.50 Mn |
| Dec 31, 2021 | -8.40 Mn |
| Sep 30, 2021 | -5.60 Mn |
| Jun 30, 2021 | -5.70 Mn |
| Mar 31, 2021 | -16.20 Mn |
| Dec 31, 2020 | -5.70 Mn |
| Sep 30, 2020 | -2.80 Mn |
API Access
Emergent BioSolutions Net Long-Term Debt Issued (Repaid) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();